29-Apr-2024
No headlines found.
Heron Therapeutics to Report First Quarter 2024 Financial Results on Tuesday, May 7, 2024
PRNewswire (Wed, 24-Apr 8:00 AM ET)
Heron Therapeutics to Host Investor Day on May 15, 2024 in New York City
PRNewswire (Thu, 11-Apr 4:05 PM ET)
Heron Therapeutics Announces Presentation at the 23rd Annual Needham Virtual Healthcare Conference
PRNewswire (Thu, 28-Mar 4:05 PM ET)
Biotech Finds Mid-Week Success Following Q4 Earnings Release
Yolowire (Fri, 15-Mar 3:30 AM ET)
Heron Therapeutics Inc is a commercial-stage biotechnology company. It is focused on improving the lives of patients by developing treatments that address some of the unmet patient needs. The company's product portfolio consists of APONVIE, SUSTOL, ZYNRELEF, and CINVANTI.
Heron Therapeutics trades on the NASDAQ stock market under the symbol HRTX.
As of April 29, 2024, HRTX stock price climbed to $2.50 with 1,763,926 million shares trading.
HRTX has a beta of 2.30, meaning it tends to be more sensitive to market movements. HRTX has a correlation of 0.06 to the broad based SPY ETF.
HRTX has a market cap of $375.18 million. This is considered a Small Cap stock.
Last quarter Heron Therapeutics reported $34 million in Revenue and -$.07 earnings per share. This beat revenue expectation by $3 million and exceeded earnings estimates by $.09.
In the last 3 years, HRTX stock traded as high as $18.80 and as low as $.50.
The top ETF exchange traded funds that HRTX belongs to (by Net Assets): VTI, VXF, IWM, IWO, SCHA.
HRTX has underperformed the market in the last year with a price return of +4.6% while the SPY ETF gained +24.2%. HRTX has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -1.2% and -15.3%, respectively, while the SPY returned +4.1% and +1.1%, respectively.
HRTX support price is $2.32 and resistance is $2.58 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that HRTX stock will trade within this expected range on the day.